Home › Cancro al seno triplo negativo › Utah › West Valley City
Studi clinici su Cancro al seno triplo negativo a West Valley City, UT
13 studi su Cancro al seno triplo negativo cercano partecipanti presso sedi a West Valley City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
In reclutamentoFase 1/2
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
In reclutamentoFase 1
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Start Mountain Region /ID# 276270, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
In reclutamentoFase 1
- START Mountain Region, LLC, West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
In reclutamentoFase 1
- START Mountain Region, West Valley City
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
In reclutamentoFase 1
- START Mountain Region, West Valley City
Studi su Cancro al seno triplo negativo in altre città
- Houston, TX42 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Los Angeles, CA27 studi
- Boston, MA26 studi
- San Antonio, TX23 studi
- St. Louis, MO21 studi
- Arlington, VA20 studi
- Atlanta, GA20 studi
- Dallas, TX18 studi
- Chicago, IL16 studi
- Columbus, OH16 studi
Altri studi a West Valley City
- Cancro del polmone non a piccole cellule25 studi
- Cancro colorettale17 studi
- Cancro al seno13 studi
- Cancro metastatico13 studi
- Cancro pancreatico12 studi
- Cancro (tutti i tipi)11 studi
- Cancro ovarico11 studi
- Carcinoma a cellule squamose della testa e del collo11 studi
- Cancro dell'endometrio10 studi
- Cancro dello stomaco8 studi
- Carcinoma a cellule squamose dell'esofago7 studi
- Carcinoma polmonare a piccole cellule7 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.